These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33382734)

  • 41. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness and safety of Ivermectin in COVID-19 patients: A prospective study at a safety-net hospital.
    Ozer M; Goksu SY; Conception R; Ulker E; Balderas RM; Mahdi M; Manning Z; To K; Effendi M; Anandakrishnan R; Whitman M; Gugnani M
    J Med Virol; 2022 Apr; 94(4):1473-1480. PubMed ID: 34811753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.
    Wu Z; Li H; Liao K; Wang Y
    J Surg Res; 2021 Jul; 263():89-101. PubMed ID: 33639374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and intensive care unit admission in patients with COVID-19 according to patients' oxygen requirements.
    Tortajada C; Colomer E; Andreu-Ballester JC; Esparcia A; Oltra C; Flores J
    J Med Virol; 2021 Mar; 93(3):1817-1823. PubMed ID: 33107607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of Outcomes and Process of Care for Patients Treated at Hospitals Dedicated for COVID-19 Care vs Other Hospitals.
    Bergman ZR; Usher M; Olson A; Chipman JG; Brunsvold ME; Beilman G; Tignanelli C; Lusczek ER
    JAMA Netw Open; 2022 Mar; 5(3):e220873. PubMed ID: 35238935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched Study.
    Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Badreldin HA; Alsalloum MA; Eljaaly K; Alharbi A; Aljehani R; Vishwakarma R; Alenazi AA; Alalawi M; Alissa A; Al Aamer K; Al Enazi H; Almusallam M; Alshehri A; Bukhari R; Alasmari G; AlQahtani MM; Al Shammari S; Alsulaymi HO; Al Sulaiman K
    J Intensive Care Med; 2023 Jun; 38(6):534-543. PubMed ID: 36683420
    [No Abstract]   [Full Text] [Related]  

  • 48. Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients - propensity-score matched case-control study.
    Tworek A; Jaroń K; Uszyńska-Kałuża B; Rydzewski A; Gil R; Deptała A; Franek E; Wójtowicz R; Życińska K; Walecka I; Cicha M; Wierzba W; Zaczyński A; Król ZJ; Rydzewska G
    Int J Infect Dis; 2021 Apr; 105():209-215. PubMed ID: 33607305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of non-COVID-19 critically ill patients during the COVID-19 pandemic : A retrospective propensity score-matched analysis.
    Bologheanu R; Maleczek M; Laxar D; Kimberger O
    Wien Klin Wochenschr; 2021 Sep; 133(17-18):942-950. PubMed ID: 33909109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
    Lian N; Xie H; Lin S; Huang J; Zhao J; Lin Q
    Clin Microbiol Infect; 2020 Jul; 26(7):917-921. PubMed ID: 32344167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of methylprednisolone therapy on hospital stay and viral clearance in patients with moderate COVID-19.
    Li X; Yuan X; Xu Z; Huang L; Shi L; Lu X; Wang FS; Fu J
    Infect Med (Beijing); 2022 Dec; 1(4):236-244. PubMed ID: 38013911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age-Propensity Score-Matched Analysis of Austrian National Public Health Institute Data.
    Aziz F; Aberer F; Bräuer A; Ciardi C; Clodi M; Fasching P; Karolyi M; Kautzky-Willer A; Klammer C; Malle O; Pawelka E; Pieber T; Peric S; Ress C; Schranz M; Sourij C; Stechemesser L; Stingl H; Stöcher H; Stulnig T; Tripolt N; Wagner M; Wolf P; Zitterl A; Reisinger AC; Siller-Matula J; Hummer M; Moser O; von-Lewinski D; Eller P; Kaser S; Sourij H
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tocilizumab versus anakinra in COVID-19: results from propensity score matching.
    Arcani R; Correard F; Suchon P; Kaplanski G; Jean R; Cauchois R; Leprince M; Arcani V; Seguier J; De Sainte Marie B; Andre B; Koubi M; Rossi P; Gayet S; Gobin N; Garrido V; Weiland J; Jouve E; Couderc AL; Villani P; Daumas A
    Front Immunol; 2023; 14():1185716. PubMed ID: 37304271
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting the response to methylprednisolone pulses in patients with SARS-COV-2 infection.
    Sarriá-Landete AJ; Crespo-Matas JA; Domínguez-Quesada I; Castellanos-Monedero JJ; Marte-Acosta D; Arias-Arias ÁJ
    Med Clin (Barc); 2022 Dec; 159(12):557-562. PubMed ID: 35718548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19.
    Gupta A; Madhavan MV; Poterucha TJ; DeFilippis EM; Hennessey JA; Redfors B; Eckhardt C; Bikdeli B; Platt J; Nalbandian A; Elias P; Cummings MJ; Nouri SN; Lawlor M; Ranard LS; Li J; Boyle C; Givens R; Brodie D; Krumholz HM; Stone GW; Sethi SS; Burkhoff D; Uriel N; Schwartz A; Leon MB; Kirtane AJ; Wan EY; Parikh SA
    Nat Commun; 2021 Feb; 12(1):1325. PubMed ID: 33637713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran.
    Allameh SF; Nemati S; Ghalehtaki R; Mohammadnejad E; Aghili SM; Khajavirad N; Beigmohammadi MT; Salehi M; Mirfazaelian H; Edalatifard M; Kazemizadeh H; Dehghan Manshadi SA; Hasannezhad M; Amoozadeh L; Radnia M; Khatami SR; Nahvijou A; Seyyedsalehi MS; Rashidian L; Ayoobi Yazdi N; Nasiri Toosi M; Sadeghniiat-Haghighi K; Jafarian A; Yunesian M; Zendehdel K
    Arch Iran Med; 2020 Nov; 23(11):766-775. PubMed ID: 33220695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Comparison of the Efficacy of Adjuvant Parenteral Methylprednisolone and Dexamethasone in Reducing Covid-19 Disease Severity and Mortality among the Moderate to Critical Patients -A Retrospective Study.
    Krishnaswamy P; Bs N; Hegde SV
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease.
    Kiser TH; Allen RR; Valuck RJ; Moss M; Vandivier RW
    Am J Respir Crit Care Med; 2014 May; 189(9):1052-64. PubMed ID: 24617842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.